Abstract
To arrive at a better understanding of the effects of the glucocorticoid component of chemotherap#y protocols on lymphocytic leukemia cells, we analysed early responses of T-lymphocytic leukemia cell lines Jurkat and CEM-C7, both of which undergo apoptosis in response to dexamethasone, via gene chips. Among genes identified as repressed, a notable cluster seemed to be of importance for the processes of transcription, mRNA splicing and protein synthesis. Consequently, we assessed time-resolved uptake of uridine and methionine to monitor RNA and protein synthesis, along with parameters quantifying apoptosis. Repression of uptake to about 65% of that in untreated cells preceded the first sign of apoptosis by several hours in both cell lines. In addition to this general repression of RNA and protein synthesis, several genes were found to be regulated that may contribute to synergistic action of glucocorticoids with other components of frequently used chemotherapy protocols such as antimetabolites, methotrexate and alkylating agents.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Albers MW, Brown EJ, Tanaka A, Williams RT, Hall FL, Schreiber SL . 1993 Ann. NY Acad. Sci. 696: 54–62
Alizadeh AA, Eisen MB, Davis RE, et al. 2000 Nature 403: 503–511
Altmeyer A, Simmons RC, Krajewski S, Reed JC, Bornkamm GW, Chen-Kiang S . 1997 Immunity 7: 667–677
Antakly T, Thompson EB, O’Donnell D . 1989 Cancer Res. 49: 2230s–2234s
Ashraf J, Kunapuli S, Chilton D, Thompson EB . 1991 J. Steroid Biochem. Mol. Biol. 38: 561–568
Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M . 1995 Science 270: 286–290
Baxter JD . 2000 Adv. Intern. Med. 45: 317–349
Baxter JD, Harris AW, Tomkins GM, Cohn M . 1971 Science 171: 189–191
Beato M, Herrlich P, Schütz G . 1995 Cell 83: 851–857
Bortner CD, Cidlowski JA . 1999 J. Biol. Chem. 274: 21953–21962
Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, Lane WS, Schreiber SL . 1994 Nature 369: 756–758
Brown EJ, Schreiber SL . 1996 Cell 86: 517–520
Burnstein KL, Jewell CM, Sar M, Cidlowski JA . 1994 Mol. Endocrinol. 8: 1764–1773
Caron-Leslie LA, Evans RB, Cidlowski JA . 1994 FASEB J. 8: 639–645
Chabner BA, Allegra CJ, Curt GA, Calabresi P . 1996 Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds.), The Pharmacological Basis of Therapeutics, 9th ed McGraw-Hill: New York pp. 1233–1271
Chapman MS, Askew DJ, Kuscuoglu U, Miesfeld RL . 1996 Mol. Endocrinol. 10: 967–978
Chaudhary N, McMahon C, Blobel G . 1991 Proc. Natl. Acad. Sci. USA 88: 8189–8193
Chen MJ, Shimada T, Moulton AD, Cline A, Humphries RK, Maizel J, Nienhuis AW . 1984 J. Biol. Chem. 259: 3933–3943
Chen Q, Baird SD, Mahadevan M, Besner-Johnston A, Farahani R, Xuan J, Kang X, Lefebvre C, Ikeda JE, Korneluk RG, MacKenzie AE . 1998 Genomics 48: 121–127
Cruzen ME, Arfin SM . 1994 DNA Seq 4: 243–248
Dayan A, Bertrand R, Beauchemin M, Chahla D, Mamo A, Filion M, Skup D, Massie B, Jolivet J . 1995 Gene 165: 307–311
Denton RR, Eisen LP, Elsasser MS, Harmon JM . 1993 Endocrinology 133: 248–256
Eisen LP, Elsasser MS, Harmon JM . 1988 J. Biol. Chem. 263: 12044–12048
Elisei R, Weightman D, Kendall-Taylor P, Vassart G, Ludgate M . 1993 J. Endocrinol. Invest. 16: 533–540
Fischer U, Liu Q, Dreyfuss G . 1997 Cell 90: 1023–1029
Foley GE, Lazarus H . 1967 Biochem. Pharmacol. 16: 659–674
Geley S, Fiegl M, Hartmann BL, Kofler R . 1996a Rev. Physiol. Biochem. Pharmacol. 128: 1–97
Geley S, Hartmann BL, Hala M, Strasser-Wozak EM, Kapelari K, Kofler R . 1996b Cancer Res. 56: 5033–5038
Gipp JJ, Bailey HH, Mulcahy RT . 1995 Biochem. Biophys. Res. Commun. 206: 584–589
Godowski PJ, Sakai DD, Yamamoto KR . 1989 DNA-Protein Interactions in Transcription, UCLA Symposia on Molecular and Cellular Biology, New Series, vol. 95. JD Gralla, Alan R, Liss (eds). New York pp. 197–210
Gomi M, Moriwaki K, Katagiri S, Kurata Y, Thompson EB . 1990 Cancer Res. 50: 1873–1878
Göttlicher M, Heck S, Herrlich P . 1998 J. Mol. Med. 76: 480–489
Harmon JM, Norman MR, Fowlkes BJ, Thompson EB . 1979 J. Cell Physiol. 98: 267–278
Hartmann BL, Geley S, Loffler M, Hattmannstorfer R, Strasser-Wozak EM, Auer B, Kofler R . 1999 Oncogene 18: 713–719
Heck S, Bender K, Kullmann M, Göttlicher M, Herrlich P, Cato AC . 1997 EMBO J. 16: 4698–4707
Helmberg A, Auphan N, Caelles C, Karin M . 1995 EMBO J. 14: 452–460
Helmberg A, Fässler R, Geley S, Jöhrer K, Kroemer G, Böck G, Kofler R . 1990 J. Immunol. 145: 4332–4337
Honore B, Rasmussen HH, Vorum H, Dejgaard K, Liu X, Gromov P, Madsen P, Gesser B, Tommerup N, Celis JE . 1995 J. Biol. Chem. 270: 28780–28789
Hortsch M, Labeit S, Meyer DI . 1988 Nucleic Acids Res. 16: 361–362
Hsieh SL, Campbell RD . 1991 Biochem J. 278: 809–816
Huang SH, Tang A, Drisco B, Zhang SQ, Seeger R, Li C, Jong A . 1994 DNA Cell Biol. 13: 461–471
Iwahana H, Fujimura M, Ii S, Kondo M, Moritani M, Takahashi Y, Yamaoka T, Yoshimoto K, Itakura M . 1996 Biochem. Biophys. Res. Commun. 219: 249–255
Karin M . 1998 Cell 93: 487–490
Kullmann M, Schneikert J, Moll J, Heck S, Zeiner M, Gehring U, Cato AC . 1998 J. Biol. Chem. 273: 14620–14625
Lipshutz RJ, Fodor SPA, Gingeras TR, Lockhart DJ . 1999 Nature Genet. 21: 1 Suppl 20–24
Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G . 1996 J. Exp. Med. 184: 1155–1160
Mita K, Tsuji H, Morimyo M, Takahashi E, Nenoi M, Ichimura S, Yamauchi M, Hongo E, Hayashi A . 1995 Gene 159: 285–286
Moulding DA, Quayle JA, Hart CA, Edwards SW . 1998 Blood 92: 2495–2502
Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C . 1991 J. Immunol. Meth. 139: 271–279
Owens-Grillo JK, Hoffmann K, Hutchison KA, Yem AW, Deibel Jr MR, Handschumacher RE, Pratt WB . 1995 J. Biol. Chem. 270: 20479–20484
Poot M, Zhang YZ, Kramer JA, Wells KS, Jones LJ, Hanzel DK, Lugade AG, Singer VL, Haugland RP . 1996 J. Histochem. Cytochem. 44: 1363–1372
Ramdas J, Liu W, Harmon JM . 1999 Cancer Res. 59: 1378–1385
Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, Schütz G . 1998 Cell 93: 531–541
Reichardt HM, Schütz G . 1998 Mol. Cell. Endocrinol. 146: 1–6
Scheinman RI, Cogswell PC, Lofquist AK, Baldwin Jr AS . 1995 Science 270: 283–286
Schimmer BP, Parker KL . 1996 Hardman JG, Limbird LE, Molinoff PB, Ruddon RW and Gilman AG . (eds). The Pharmacological Basis of Therapeutics, 9th edn McGraw-Hill: New York pp. 1465–1481
Schrank B, Gotz R, Gunnersen JM, Ure JM, Toyka KV, Smith AG, Sendtner M . 1997 Proc. Natl. Acad. Sci. USA 94: 9920–9925
Seelig HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E . 1995 Arthritis Rheum. 38: 1389–1399
Sibley CH, Tomkins GM . 1974 Cell 2: 213–220
Sillekens PT, Beijer RP, Habets WJ, van Venrooij WJ . 1988 Nucleic Acids Res. 16: 8307–8321
Silverstein AM, Galigniana MD, Chen MS, Owens-Grillo JK, Chinkers M, Pratt WB . 1997 J. Biol. Chem. 272: 16224–16230
Silverstein AM, Galigniana MD, Kanelakis KC, Radanyi C, Renoir JM, Pratt WB . 1999 J. Biol. Chem. 274: 36980–36986
Tai PK, Albers MW, Chang H, Faber LE, Schreiber SL . 1992 Science 256: 1315–1318
Thompson EB . 1999 Trends Endocrinol. Metab. 10: 353–358
Thulasi R, Harbour DV, Thompson EB . 1993 J. Biol. Chem. 268: 18306–18312
Tonko M, Ausserlechner MJ, Bernhard D, Helmberg A, Kofler R . 2001 FASEB J. 15: 693–699
Tsui FW, Siminovitch L . 1987 Nucleic Acids Res. 15: 3349–3367
Wang W, Xue Y, Zhou S, Kuo A, Cairns BR, Crabtree GR . 1996 Genes Dev. 10: 2117–2130
Webster JC, Cidlowski JA . 1999 Trends Endocrinol. Metab. 10: 396–402
Weinzierl RO, Ruppert S, Dynlacht BD, Tanese N, Tjian R . 1993 EMBO J. 12: 5303–5309
Yoon JB, Roeder RG . 1996 Mol. Cell. Biol. 16: 1–9
Zeiner M, Gebauer M, Gehring U . 1997 EMBO J. 16: 5483–5490
Zeiner M, Gehring U . 1995 Proc. Natl. Acad. Sci. USA 92: 11465–11469
Zeiner M, Niyaz Y, Gehring U . 1999 Proc. Natl. Acad. Sci. USA 96: 10194–10199
Acknowledgements
We would like to thank Dr G Böck for help with flow cytometry, Yvonne Burki for expert assistance with gene chip hybridization, and Drs Georg Wick, Roswitha Sgonc, Stephan Geley, Michael J Ausserlechner and Wolfgang Doppler for critical reading, and MK Occhipinti for editing the manuscript. This work was supported by grants P11306 and F204 from the Austrian Science Fund.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Obexer, P., Certa, U., Kofler, R. et al. Expression profiling of glucocorticoid-treated T-ALL cell lines: rapid repression of multiple genes involved in RNA-, protein- and nucleotide synthesis. Oncogene 20, 4324–4336 (2001). https://doi.org/10.1038/sj.onc.1204573
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204573
Keywords
This article is cited by
-
Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes
Cell Death & Disease (2013)
-
Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia
BMC Genomics (2011)
-
Establishing a sensitive and specific assay for determination of glucocorticoid bioactivity
Wiener klinische Wochenschrift (2011)
-
Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids
Cancer Cell International (2007)
-
Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia
Leukemia (2007)